524654 Stock Overview
Natural Capsules Limited engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Natural Capsules Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹355.10 |
| 52 Week High | ₹498.90 |
| 52 Week Low | ₹295.00 |
| Beta | 0.72 |
| 1 Month Change | 16.33% |
| 3 Month Change | -2.18% |
| 1 Year Change | -24.41% |
| 3 Year Change | 153.82% |
| 5 Year Change | 400.14% |
| Change since IPO | 926.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524654 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 9.7% | 1.4% | 2.8% |
| 1Y | -24.4% | 57.2% | 46.6% |
Return vs Industry: 524654 underperformed the Indian Pharmaceuticals industry which returned 57.2% over the past year.
Return vs Market: 524654 underperformed the Indian Market which returned 46.6% over the past year.
Price Volatility
| 524654 volatility | |
|---|---|
| 524654 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524654 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524654's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 177 | Sunil Laxminarayana Mundra | www.naturalcapsules.com |
Natural Capsules Limited engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, halal certified gelatin, fast release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form.
Natural Capsules Limited Fundamentals Summary
| 524654 fundamental statistics | |
|---|---|
| Market cap | ₹3.29b |
| Earnings (TTM) | ₹72.46m |
| Revenue (TTM) | ₹1.53b |
45.4x
P/E Ratio2.2x
P/S RatioIs 524654 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524654 income statement (TTM) | |
|---|---|
| Revenue | ₹1.53b |
| Cost of Revenue | ₹788.65m |
| Gross Profit | ₹739.60m |
| Other Expenses | ₹667.13m |
| Earnings | ₹72.46m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.82 |
| Gross Margin | 48.40% |
| Net Profit Margin | 4.74% |
| Debt/Equity Ratio | 49.0% |
How did 524654 perform over the long term?
See historical performance and comparison